Regis Reveals New Potent Compound Capabilities at InformEx 2015
Regis Technologies announced it will unveil its new potent compound capabilities at InformEx 2015, Feb. 3-5.
Regis Technologies, a contract manufacturing organization (CMO), announced that Wayne Nowicki, director of business development for the company, unveiled the details of its Potent Compound Suite (PCS) at a press conference held on Feb. 3, 2015. An expansion to the company’s Morton Grove, Illinois facility will give the PCS the ability to provide for small molecule cGMP manufacturing of potent compounds up to about one kilogram per batch.
According to a press release, the project was designed and constructed based on existing potent-compound handling requirements. The facility needed to be specially equipped with isolators, laminar flow hoods, and local exhaust ventilation to minimize containment risks. After a facility redesign, including relocation of chemical storage and office construction of new offices, Regis worked with Flow Sciences, a design and manufacture containment solution for research and development laboratories, to manufacture the containment isolator.
According to Flow Sciences, its containment solutions protect operators from exposure to hazardous particulates and vapors while performing operations.
Sources:
PR WebRegisInformExFlow Sciences
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
